Antagonism of stromal cell-derived factor-1α reduces infarct size and improves ventricular function after myocardial infarction

Pflugers Archiv European Journal of Physiology

Volumn 455, Issue 2, 2007, Pages 241-250

  Proulx, Cindy ^a,b   El Helou, Viviane ^a,b   Gosselin, Hugues ^b   Clement, Robert ^b   Gillis, Marc Antoine ^b   Villeneuve, Louis ^b   Calderone, Angelino ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

AMD3100; Cardiac myocytes; Hypertrophy; Myocardial infarction; Rat; Scar; Stromal cell derived 1

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); LEUCINE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG POTENCY; GENE EXPRESSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; IMMUNOREACTIVITY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SCAR FORMATION; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE;

ANIMALS; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; HETEROCYCLIC COMPOUNDS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR4; RNA, MESSENGER; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 35148816977     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-007-0284-5     Document Type: Article

References (32)

1. 2+-ATPase overexpression in postinfarction rat myocytes. J Appl Physiol 98:2169-2176
2. Askari AT, Unzek S, Popovic ZB et al (2003) Effect of stromal cell-derived factor-1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-703
3. Broxmeyer HE, Orschell CM, Clapp DW et al (2005) Rapid mobilization of human and murine hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201:1307-1308
4. Calderone A, Abdelaziz N, Colombo F, Schreiber KL, Rindt H (2000) A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression. J Mol Cell Cardiol 32:1127-1140
5. Dawn Abbot J, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110:3300-3305
6. De Klerck B, Geboes L, Hatse S et al (2005) Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen induced arthritis. Arthritis Res Ther 7:R1208-R1220
7. El-Helou V, Bel-Hadj S, Drapeau J, Clement R, Gosselin H, Calderone A (2006) Nitric oxide-mediated inhibition of DNA synthesis was attenuated in hypertrophied neonatal rat ventricular myocytes. Nitric Oxide 14:316-326
8. (+) neural stem cells and fibres were detected in the normal and damaged rat myocardium. Hypertension 46:1219-1225
9. Hatse S, Princen K, Bridger G, De Clerq E, Schols D (2002) Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527:255-262
10. Hendrix CW, Flexner C, MacFarland RT et al (2000) Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 44:1667-1673
11. Hoffmeyer MR, Scalia R, Ross CR, Jones SP, Lefer DJ (2000) PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice. Am J Physiol 279:H2824-H2828
12. Kuwahara F, Kai H, Tokuda K et al (2002) Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106:130-135
13. Liles WC, Broxmeyer HE, Rodger E et al (2003) Mobilization of hematopoietic progenitor cells in health volunteers by AMD3100, a CXCR4 antagonist. Blood 102:2728-2730
14. Ma J, Ge J, Zhang S et al (2005) Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow cells in rats with experimental myocardial infarction. Basic Res Cardiol 100:217-223
15. A receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis. Br J Pharmacol 136:685-692
16. Molkentin JD, Lu JR, Antos CL, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228
17. 1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI. Br J Pharmacol 138:1485-1494
18. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705
19. Plllarisetti K, Gupta SK (2001) Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1): SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 25:293-300
20. Pyo RT, Sui J, Dhume A et al (2006) CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol 41:834-844
21. Qi M, Shannon TR, Euler DE, Bers DM, Samarel AM (1997) Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy. Am J Physiol 272:H2416-H2424
22. Rubin JB, Kung AL, Klein RS et al (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100:13513-13518
23. Schober A, Knarren S, Lietz M, Lin EA, Weber C (2003) Crucial role of stromal cell-derived factor-1á in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 108:2491-2497
24. Segret A, Ricker-Martin C, Pavoine C et al (2007) Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes. J Histochem Cytochem 55:141-150
25. Shepherd RM, Capoccia BJ, Devine SM et al (2006) Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108:3662-3667
26. Suratt BT, Petty JM, Young SK et al (2004) Role of CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood 104:565-571
27. Tarzami ST, Miao W, Lopez L, Factor SM, Berman JW, Kitsis RN (2003) Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection. Circulation 108:2387-2392
28. Ti TLY, Chen J, Bao W et al (2001) In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 104:2588-2594
29. Wang Y, Ahmad N, Wani MA, Ashraf M (2004) Hepatocyte growth factor prevents ventricular remodelling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol 37:1041-1052
30. Yamaguchi J, Kusano KF, Masuo O et al (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-1328
31. 2+-ATPase expression in the hypertrophic and failing heart. Can J Physiol Pharmacol 84:509-521
32. 2+ content in adult myocytes. Am J Physiol Cell Physiol 281:H2079-H2088